𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Production of a monoclonal antibody against human amelogenin

✍ Scribed by J. Catalano-Sherman; R. Laskov; A. Palmon; S. David; D. Deutsch


Publisher
Springer
Year
1994
Tongue
English
Weight
891 KB
Volume
54
Category
Article
ISSN
1432-0827

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Production and characterization of monoc
✍ S. M. SchΓΆnmann; J. Iyer; H. Laeng; H. A. Gerber; H. KΓ€ser; K. Blaser πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 French βš– 738 KB

MAb were derived from mice immunized with cells of the human neuroblastoma line IMR-32. Five hybridomas were selected according to their selective binding to human cell lines, tumors and normal tissues. One of them, CE7, reacted with all sympatho-adrenomedullary cells (neuroblastoma, ganglioneurobla

Monoclonal antibodies against human pros
✍ Nilsson, B. Ove; Jin, Meishan; Einarsson, Barbro; Persson, Bo-Eric; Ronquist, Gu πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 447 KB

## Background: The prostasomes are secreted into the gland ducts of the human prostate. at ejaculation, these native prostasomes are expelled with the secretions of the prostate and appear in the seminal plasma as seminal prostasomes, where they facilitate sperm function in various ways. we have de

Monoclonal antibody against human bone a
✍ K. Masuhara; R. Yoshikawa; K. Takaoka; K. Ono; D. C. Morris; H. C. Anderson πŸ“‚ Article πŸ“… 1991 πŸ› Springer 🌐 English βš– 318 KB

A monoclonal antibody which reacts preferentially with human bone alkaline phosphatase (AP) has been developed using human osteosarcoma bone AP as an immunogen. The antibody with the highest selectivity shows about three- and a-half fold greater binding to bone than to liver AP. The selectivity was

Characterization of monoclonal antibodie
✍ Setsuko Kitaoka; Norio Fukuhara; Fumiyo Tazawa; Hiroshi Suzuki; Tetsuo Sato; Dr. πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 754 KB

Three monoclonal antibodies capable of specifically inhibiting hemagglutination of human rotavirus were produced. Their hemagglutination inhibition (HI) activity was specific to the homologous strain (KUN) used for immunization. The monoclonal antibodies with HI activity were highly effective in neu